{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:38:20Z","timestamp":1792427900325,"version":"4.5.0"},"reference-count":52,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The aim of this study was to compare outcomes in cancer patients treated with middle meningeal artery embolization (MMAE) versus surgical treatment for chronic subdural hematomas (cSDHs), with outcome measures of requirement of rescue treatment and time to resumption of previously held systemic cancer therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted that included a review of medical records of cancer patients with cSDH treated with MMAE or surgical drainage. Patients without adequate follow-up including radiological follow-up and patients who underwent dual therapy (i.e., MMAE plus surgery) were excluded. The primary outcome was the requirement for rescue treatment within 180 days, defined as surgical reintervention or repeat embolization due to hematoma progression or symptom recurrence. Secondary outcomes included the time to resumption of previously held systemic cancer therapy. Inverse probability of treatment weighting using covariate balancing propensity scores was used to adjust for baseline differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 110 patients were included. Of these patients, 54 received MMAE and 56 were treated with surgical drainage. No significant differences were found regarding baseline demographic features. Although patients in the surgery group had a higher incidence of headaches and dizziness preoperatively, no difference in preoperative motor deficits was found. The MMAE group had a higher incidence of clotting disturbances and thrombocytopenia. Within 180 days, 5.6% of the patients who underwent MMAE required rescue treatment, all performed through surgical drainage. In contrast, 30.4% of the surgically treated patients required rescue treatment that included surgery, MMAE, or a combination of both. A Poisson regression analysis for rescue treatment within 180 days demonstrated that patients treated with MMAE had an 87.5% lower incidence rate of rescue treatment compared with those who underwent surgical drainage (p = 0.001). Additionally, the surgery group received significantly more postoperative platelet transfusions (median of 6 units) when compared with 0 units in the MMAE group. Time to restart previously held chemotherapy was significantly shorter in the MMAE group (p = 0.005).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>MMAE as a primary therapy for cSDH in cancer patients was associated with lower recurrence rates, earlier resumption of cancer therapy, reduction in platelet transfusion, and shorter hospitalizations compared with surgical drainage. These findings suggest that MMAE alone is safe and effective, and facilitates earlier resumption of chemotherapy in the oncology population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2025.7.focus25553","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:12:30Z","timestamp":1759317150000},"page":"E14","source":"Crossref","is-referenced-by-count":5,"title":["Chronic subdural hematoma treatment in oncological patients: middle meningeal artery embolization versus surgical drainage"],"prefix":"10.3171","volume":"59","author":[{"given":"Esteban","family":"Ramirez-Ferrer","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Zuluaga-Garcia","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibawanye I.","family":"Ene","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaan M.","family":"Raza","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick F.","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston;"},{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"2","key":"b1","series-title":"Neurosurgery","first-page":"304","article-title":"Randomized trial comparing burr hole craniostomy, minicraniotomy, and twist drill craniostomy for treatment of chronic subdural hematoma","volume":"91","author":"Duerinck J","year":"2022","unstructured":"Duerinck J, Van Der Veken J, Schuind S,  Randomized trial comparing burr hole craniostomy, minicraniotomy, and twist drill craniostomy for treatment of chronic subdural hematoma. Neurosurgery. 2022;91(2):304-311."},{"issue":"12","key":"b2","series-title":"Acta Neurochir (Wien)","first-page":"3229","article-title":"Twist drill craniostomy vs burr hole drainage of chronic subdural hematoma: a systematic review and meta-analysis","volume":"163","author":"Yagnik KJ","year":"2021","unstructured":"Yagnik KJ, Goyal A, Van Gompel JJ. Twist drill craniostomy vs burr hole drainage of chronic subdural hematoma: a systematic review and meta-analysis. Acta Neurochir (Wien). 2021;163(12):3229-3241."},{"issue":"8","key":"b3","series-title":"Cochrane Database Syst Rev","first-page":"CD011402","article-title":"External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults","volume":"2016","author":"Peng D","year":"2016","unstructured":"Peng D, Zhu Y. External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults. Cochrane Database Syst Rev. 2016;2016(8):CD011402."},{"issue":"20","key":"b4","series-title":"N Engl J Med","first-page":"1901","article-title":"Middle meningeal artery embolization for nonacute subdural hematoma","volume":"391","author":"Liu J","year":"2024","unstructured":"Liu J, Ni W, Zuo Q,  Middle meningeal artery embolization for nonacute subdural hematoma. N Engl J Med. 2024;391(20):1901-1912."},{"issue":"6","key":"b5","series-title":"Neurosurgery","first-page":"801","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases","volume":"85","author":"Link TW","year":"2019","unstructured":"Link TW, Boddu S, Paine SM, Kamel H, Knopman J. Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases. Neurosurgery. 2019;85(6):801-807."},{"key":"b6","series-title":"World Neurosurg","first-page":"613","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review","volume":"122","author":"Srivatsan A","year":"2019","unstructured":"Srivatsan A, Mohanty A, Nascimento FA,  Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review. World Neurosurg. 2019;122:613\u2013619."},{"issue":"2","key":"b7","series-title":"Neurosurgery","first-page":"268","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations","volume":"88","author":"Kan P","year":"2021","unstructured":"Kan P, Maragkos GA, Srivatsan A,  Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations. Neurosurgery. 2021;88(2):268-277."},{"issue":"4","key":"b8","series-title":"J Neurosurg","first-page":"1208","article-title":"A propensity-adjusted comparison of middle meningeal artery embolization versus conventional therapy for chronic subdural hematomas","volume":"135","author":"Catapano JS","year":"2021","unstructured":"Catapano JS, Ducruet AF, Nguyen CL,  A propensity-adjusted comparison of middle meningeal artery embolization versus conventional therapy for chronic subdural hematomas. J Neurosurg. 2021;135(4):1208\u20131213."},{"issue":"1","key":"b9","series-title":"Neurosurgery","first-page":"74","article-title":"Subdural hematoma in patients with cancer","volume":"71","author":"Reichman J","year":"2012","unstructured":"Reichman J, Singer S, Navi B,  Subdural hematoma in patients with cancer. Neurosurgery. 2012;71(1):74\u201379."},{"key":"b10","series-title":"Clin Epidemiol","first-page":"629","article-title":"Non-traumatic subdural hematoma and cancer: a cohort study","volume":"15","author":"Okholm SH","year":"2023","unstructured":"Okholm SH, Nagy D, K\u00f6rmendin\u00e9 Farkas D,  Non-traumatic subdural hematoma and cancer: a cohort study. Clin Epidemiol. 2023;15:629\u2013633."},{"key":"b11","series-title":"World Neurosurg","first-page":"714","article-title":"Presence of a malignant tumor as a novel predictive factor for repeated recurrences of chronic subdural hematoma","volume":"105","author":"Hori YS","year":"2017","unstructured":"Hori YS, Aoi M, Oda K, Fukuhara T. Presence of a malignant tumor as a novel predictive factor for repeated recurrences of chronic subdural hematoma. World Neurosurg. 2017;105:714\u2013719."},{"issue":"20","key":"b12","series-title":"N Engl J Med","first-page":"1890","article-title":"Adjunctive middle meningeal artery embolization for subdural hematoma","volume":"391","author":"Davies JM","year":"2024","unstructured":"Davies JM, Knopman J, Mokin M,  Adjunctive middle meningeal artery embolization for subdural hematoma. N Engl J Med. 2024;391(20):1890-1900."},{"key":"b13","series-title":"World Neurosurg","first-page":"e1061","article-title":"Subdural hematoma in patients with hematologic malignancies: an outcome analysis and examination of risk factors of operative and nonoperative management","volume":"130","author":"Wright CH","year":"2019","unstructured":"Wright CH, Wright J, Alonso A,  Subdural hematoma in patients with hematologic malignancies: an outcome analysis and examination of risk factors of operative and nonoperative management. World Neurosurg. 2019;130:e1061\u2013e1069."},{"issue":"5","key":"b14","series-title":"J Neurosurg","first-page":"1273","article-title":"Middle meningeal artery embolization for chronic subdural hematoma in cancer patients with refractory thrombocytopenia","volume":"136","author":"Lee S","year":"2022","unstructured":"Lee S, Srivatsan A, Srinivasan VM,  Middle meningeal artery embolization for chronic subdural hematoma in cancer patients with refractory thrombocytopenia. J Neurosurg. 2022;136(5):1273-1277."},{"issue":"2","key":"b15","series-title":"Neurocrit Care","first-page":"294","article-title":"The neurocritical and neurosurgical care of subdural hematomas","volume":"24","author":"Huang KT","year":"2016","unstructured":"Huang KT, Bi WL, Abd-El-Barr M,  The neurocritical and neurosurgical care of subdural hematomas. Neurocrit Care. 2016;24(2):294-307."},{"issue":"Suppl 1","key":"b16","series-title":"Anaesthesia","first-page":"21","article-title":"Chronic subdural haematoma: the role of peri-operative medicine in a common form of reversible brain injury","volume":"77","author":"Stubbs DJ","year":"2022","unstructured":"Stubbs DJ, Davies BM, Menon DK. Chronic subdural haematoma: the role of peri-operative medicine in a common form of reversible brain injury. Anaesthesia. 2022;77 Suppl 1:21\u201333"},{"issue":"7","key":"b17","series-title":"Ann Surg Oncol","first-page":"1904","article-title":"Surgical risk factors for the delayed initiation of adjuvant chemotherapy in breast cancer","volume":"25","author":"Riba LA","year":"2018","unstructured":"Riba LA, Gruner RA, Fleishman A, James TA. Surgical risk factors for the delayed initiation of adjuvant chemotherapy in breast cancer. Ann Surg Oncol. 2018;25(7):1904-1911."},{"issue":"1","key":"b18","series-title":"Eur J Cancer","first-page":"142","article-title":"Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials","volume":"49","author":"Mahner S","year":"2013","unstructured":"Mahner S, Eulenburg C, Staehle A,  Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials. Eur J Cancer. 2013;49(1):142\u2013149."},{"issue":"1","key":"b19","series-title":"Gynecol Oncol","first-page":"54","article-title":"Prolonged interruption of chemotherapy in patients undergoing delayed debulking surgery for advanced high grade serous ovarian cancer is associated with a worse prognosis","volume":"158","author":"Searle G","year":"2020","unstructured":"Searle G, Pounds R, Phillips A,  Prolonged interruption of chemotherapy in patients undergoing delayed debulking surgery for advanced high grade serous ovarian cancer is associated with a worse prognosis. Gynecol Oncol. 2020;158(1):54\u201358."},{"issue":"6","key":"b20","series-title":"Neurosurgery","first-page":"1142","article-title":"Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis","volume":"92","author":"Sattari SA","year":"2023","unstructured":"Sattari SA, Yang W, Shahbandi A,  Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis. Neurosurgery. 2023;92(6):1142-1154."},{"issue":"7","key":"b21","series-title":"Eur J Surg Oncol","first-page":"969","article-title":"In-hospital length of stay after major surgical oncological procedures","volume":"44","author":"Nazzani S","year":"2018","unstructured":"Nazzani S, Preisser F, Mazzone E,  In-hospital length of stay after major surgical oncological procedures. Eur J Surg Oncol. 2018;44(7):969-974."},{"issue":"7","key":"b22","series-title":"J Clin Oncol","first-page":"1907","article-title":"Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation","volume":"20","author":"Prieto JM","year":"2002","unstructured":"Prieto JM, Blanch J, Atala J,  Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20(7):1907\u20131917."},{"issue":"13","key":"b23","series-title":"Leuk Lymphoma","first-page":"2101","article-title":"Treatment patterns, resource utilization and clinical outcomes in patients with higher risk myelodysplastic syndromes (MDS) in United States community practices","volume":"64","author":"Egloff SA","year":"2023","unstructured":"Egloff SA, Cao X, Lachs R,  Treatment patterns, resource utilization and clinical outcomes in patients with higher risk myelodysplastic syndromes (MDS) in United States community practices. Leuk Lymphoma. 2023;64(13):2101-2112."},{"issue":"10","key":"b24","series-title":"Surg Endosc","first-page":"7549","article-title":"Healthcare resource utilization after surgical treatment of cancer: value of minimally invasive surgery","volume":"36","author":"Ricciardi R","year":"2022","unstructured":"Ricciardi R, Goldstone RN, Francone T,  Healthcare resource utilization after surgical treatment of cancer: value of minimally invasive surgery. Surg Endosc. 2022;36(10):7549-7560."},{"issue":"5","key":"b25","series-title":"J Neurosurg","first-page":"1117","article-title":"Predictive factors for recurrence and clinical outcomes in patients with chronic subdural hematoma","volume":"127","author":"Han MH","year":"2017","unstructured":"Han MH, Ryu JI, Kim CH, Kim JM, Cheong JH, Yi HJ. Predictive factors for recurrence and clinical outcomes in patients with chronic subdural hematoma. J Neurosurg. 2017;127(5):1117-1125."},{"issue":"6","key":"b26","series-title":"Neurosurgery","first-page":"842","article-title":"Management of chronic subdural hematoma: a systematic review and component network meta-analysis of 455 studies with 103 645 cases","volume":"91","author":"Henry J","year":"2022","unstructured":"Henry J, Amoo M, Kissner M,  Management of chronic subdural hematoma: a systematic review and component network meta-analysis of 455 studies with 103 645 cases. Neurosurgery. 2022;91(6):842-855."},{"issue":"2","key":"b1","series-title":"Neurosurgery","first-page":"304","article-title":"Randomized trial comparing burr hole craniostomy, minicraniotomy, and twist drill craniostomy for treatment of chronic subdural hematoma","volume":"91","author":"Duerinck J","year":"2022","unstructured":"Duerinck J, Van Der Veken J, Schuind S,  Randomized trial comparing burr hole craniostomy, minicraniotomy, and twist drill craniostomy for treatment of chronic subdural hematoma. Neurosurgery. 2022;91(2):304-311."},{"issue":"12","key":"b2","series-title":"Acta Neurochir (Wien)","first-page":"3229","article-title":"Twist drill craniostomy vs burr hole drainage of chronic subdural hematoma: a systematic review and meta-analysis","volume":"163","author":"Yagnik KJ","year":"2021","unstructured":"Yagnik KJ, Goyal A, Van Gompel JJ. Twist drill craniostomy vs burr hole drainage of chronic subdural hematoma: a systematic review and meta-analysis. Acta Neurochir (Wien). 2021;163(12):3229-3241."},{"issue":"8","key":"b3","series-title":"Cochrane Database Syst Rev","first-page":"CD011402","article-title":"External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults","volume":"2016","author":"Peng D","year":"2016","unstructured":"Peng D, Zhu Y. External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults. Cochrane Database Syst Rev. 2016;2016(8):CD011402."},{"issue":"20","key":"b4","series-title":"N Engl J Med","first-page":"1901","article-title":"Middle meningeal artery embolization for nonacute subdural hematoma","volume":"391","author":"Liu J","year":"2024","unstructured":"Liu J, Ni W, Zuo Q,  Middle meningeal artery embolization for nonacute subdural hematoma. N Engl J Med. 2024;391(20):1901-1912."},{"issue":"6","key":"b5","series-title":"Neurosurgery","first-page":"801","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases","volume":"85","author":"Link TW","year":"2019","unstructured":"Link TW, Boddu S, Paine SM, Kamel H, Knopman J. Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases. Neurosurgery. 2019;85(6):801-807."},{"key":"b6","series-title":"World Neurosurg","first-page":"613","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review","volume":"122","author":"Srivatsan A","year":"2019","unstructured":"Srivatsan A, Mohanty A, Nascimento FA,  Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review. World Neurosurg. 2019;122:613\u2013619."},{"issue":"2","key":"b7","series-title":"Neurosurgery","first-page":"268","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations","volume":"88","author":"Kan P","year":"2021","unstructured":"Kan P, Maragkos GA, Srivatsan A,  Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations. Neurosurgery. 2021;88(2):268-277."},{"issue":"4","key":"b8","series-title":"J Neurosurg","first-page":"1208","article-title":"A propensity-adjusted comparison of middle meningeal artery embolization versus conventional therapy for chronic subdural hematomas","volume":"135","author":"Catapano JS","year":"2021","unstructured":"Catapano JS, Ducruet AF, Nguyen CL,  A propensity-adjusted comparison of middle meningeal artery embolization versus conventional therapy for chronic subdural hematomas. J Neurosurg. 2021;135(4):1208\u20131213."},{"issue":"1","key":"b9","series-title":"Neurosurgery","first-page":"74","article-title":"Subdural hematoma in patients with cancer","volume":"71","author":"Reichman J","year":"2012","unstructured":"Reichman J, Singer S, Navi B,  Subdural hematoma in patients with cancer. Neurosurgery. 2012;71(1):74\u201379."},{"key":"b10","series-title":"Clin Epidemiol","first-page":"629","article-title":"Non-traumatic subdural hematoma and cancer: a cohort study","volume":"15","author":"Okholm SH","year":"2023","unstructured":"Okholm SH, Nagy D, K\u00f6rmendin\u00e9 Farkas D,  Non-traumatic subdural hematoma and cancer: a cohort study. Clin Epidemiol. 2023;15:629\u2013633."},{"key":"b11","series-title":"World Neurosurg","first-page":"714","article-title":"Presence of a malignant tumor as a novel predictive factor for repeated recurrences of chronic subdural hematoma","volume":"105","author":"Hori YS","year":"2017","unstructured":"Hori YS, Aoi M, Oda K, Fukuhara T. Presence of a malignant tumor as a novel predictive factor for repeated recurrences of chronic subdural hematoma. World Neurosurg. 2017;105:714\u2013719."},{"issue":"20","key":"b12","series-title":"N Engl J Med","first-page":"1890","article-title":"Adjunctive middle meningeal artery embolization for subdural hematoma","volume":"391","author":"Davies JM","year":"2024","unstructured":"Davies JM, Knopman J, Mokin M,  Adjunctive middle meningeal artery embolization for subdural hematoma. N Engl J Med. 2024;391(20):1890-1900."},{"key":"b13","series-title":"World Neurosurg","first-page":"e1061","article-title":"Subdural hematoma in patients with hematologic malignancies: an outcome analysis and examination of risk factors of operative and nonoperative management","volume":"130","author":"Wright CH","year":"2019","unstructured":"Wright CH, Wright J, Alonso A,  Subdural hematoma in patients with hematologic malignancies: an outcome analysis and examination of risk factors of operative and nonoperative management. World Neurosurg. 2019;130:e1061\u2013e1069."},{"issue":"5","key":"b14","series-title":"J Neurosurg","first-page":"1273","article-title":"Middle meningeal artery embolization for chronic subdural hematoma in cancer patients with refractory thrombocytopenia","volume":"136","author":"Lee S","year":"2022","unstructured":"Lee S, Srivatsan A, Srinivasan VM,  Middle meningeal artery embolization for chronic subdural hematoma in cancer patients with refractory thrombocytopenia. J Neurosurg. 2022;136(5):1273-1277."},{"issue":"2","key":"b15","series-title":"Neurocrit Care","first-page":"294","article-title":"The neurocritical and neurosurgical care of subdural hematomas","volume":"24","author":"Huang KT","year":"2016","unstructured":"Huang KT, Bi WL, Abd-El-Barr M,  The neurocritical and neurosurgical care of subdural hematomas. Neurocrit Care. 2016;24(2):294-307."},{"issue":"Suppl 1","key":"b16","series-title":"Anaesthesia","first-page":"21","article-title":"Chronic subdural haematoma: the role of peri-operative medicine in a common form of reversible brain injury","volume":"77","author":"Stubbs DJ","year":"2022","unstructured":"Stubbs DJ, Davies BM, Menon DK. Chronic subdural haematoma: the role of peri-operative medicine in a common form of reversible brain injury. Anaesthesia. 2022;77 Suppl 1:21\u201333"},{"issue":"7","key":"b17","series-title":"Ann Surg Oncol","first-page":"1904","article-title":"Surgical risk factors for the delayed initiation of adjuvant chemotherapy in breast cancer","volume":"25","author":"Riba LA","year":"2018","unstructured":"Riba LA, Gruner RA, Fleishman A, James TA. Surgical risk factors for the delayed initiation of adjuvant chemotherapy in breast cancer. Ann Surg Oncol. 2018;25(7):1904-1911."},{"issue":"1","key":"b18","series-title":"Eur J Cancer","first-page":"142","article-title":"Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials","volume":"49","author":"Mahner S","year":"2013","unstructured":"Mahner S, Eulenburg C, Staehle A,  Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials. Eur J Cancer. 2013;49(1):142\u2013149."},{"issue":"1","key":"b19","series-title":"Gynecol Oncol","first-page":"54","article-title":"Prolonged interruption of chemotherapy in patients undergoing delayed debulking surgery for advanced high grade serous ovarian cancer is associated with a worse prognosis","volume":"158","author":"Searle G","year":"2020","unstructured":"Searle G, Pounds R, Phillips A,  Prolonged interruption of chemotherapy in patients undergoing delayed debulking surgery for advanced high grade serous ovarian cancer is associated with a worse prognosis. Gynecol Oncol. 2020;158(1):54\u201358."},{"issue":"6","key":"b20","series-title":"Neurosurgery","first-page":"1142","article-title":"Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis","volume":"92","author":"Sattari SA","year":"2023","unstructured":"Sattari SA, Yang W, Shahbandi A,  Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis. Neurosurgery. 2023;92(6):1142-1154."},{"issue":"7","key":"b21","series-title":"Eur J Surg Oncol","first-page":"969","article-title":"In-hospital length of stay after major surgical oncological procedures","volume":"44","author":"Nazzani S","year":"2018","unstructured":"Nazzani S, Preisser F, Mazzone E,  In-hospital length of stay after major surgical oncological procedures. Eur J Surg Oncol. 2018;44(7):969-974."},{"issue":"7","key":"b22","series-title":"J Clin Oncol","first-page":"1907","article-title":"Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation","volume":"20","author":"Prieto JM","year":"2002","unstructured":"Prieto JM, Blanch J, Atala J,  Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20(7):1907\u20131917."},{"issue":"13","key":"b23","series-title":"Leuk Lymphoma","first-page":"2101","article-title":"Treatment patterns, resource utilization and clinical outcomes in patients with higher risk myelodysplastic syndromes (MDS) in United States community practices","volume":"64","author":"Egloff SA","year":"2023","unstructured":"Egloff SA, Cao X, Lachs R,  Treatment patterns, resource utilization and clinical outcomes in patients with higher risk myelodysplastic syndromes (MDS) in United States community practices. Leuk Lymphoma. 2023;64(13):2101-2112."},{"issue":"10","key":"b24","series-title":"Surg Endosc","first-page":"7549","article-title":"Healthcare resource utilization after surgical treatment of cancer: value of minimally invasive surgery","volume":"36","author":"Ricciardi R","year":"2022","unstructured":"Ricciardi R, Goldstone RN, Francone T,  Healthcare resource utilization after surgical treatment of cancer: value of minimally invasive surgery. Surg Endosc. 2022;36(10):7549-7560."},{"issue":"5","key":"b25","series-title":"J Neurosurg","first-page":"1117","article-title":"Predictive factors for recurrence and clinical outcomes in patients with chronic subdural hematoma","volume":"127","author":"Han MH","year":"2017","unstructured":"Han MH, Ryu JI, Kim CH, Kim JM, Cheong JH, Yi HJ. Predictive factors for recurrence and clinical outcomes in patients with chronic subdural hematoma. J Neurosurg. 2017;127(5):1117-1125."},{"issue":"6","key":"b26","series-title":"Neurosurgery","first-page":"842","article-title":"Management of chronic subdural hematoma: a systematic review and component network meta-analysis of 455 studies with 103 645 cases","volume":"91","author":"Henry J","year":"2022","unstructured":"Henry J, Amoo M, Kissner M,  Management of chronic subdural hematoma: a systematic review and component network meta-analysis of 455 studies with 103 645 cases. Neurosurgery. 2022;91(6):842-855."}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/59\/4\/article-pE14.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/59\/4\/article-pE14.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/59\/4\/article-pE14.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:16:30Z","timestamp":1780128990000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/59\/4\/article-pE14.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":52,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2025.7.focus25553","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}